Biphasic Regulation of Hydrogen Sulfide in Inflammation.
Hua Wang,Zhou Shu-lai,Gong Fang-qi
DOI: https://doi.org/10.3760/cma.j.issn.0366-6999.20122557
IF: 6.133
2013-01-01
Chinese Medical Journal
Abstract:Hydrogen sulfide (H2S), which was formerly recognized as a colorless, toxic gas, was recently reported to be a novel gasotransmitter. Cystathionine β-synthase (CBS) and cystathionine γ-lyase (CSE) are the two main H2S-generating enzymes characterized by tissue-specific expression. CSE is predominantly located in the heart.1 Like its two cousins nitric oxide (NO) and carbon monoxide (CO), H2S is a simple inorganic molecule with similar properties, such as rapid diffusion and a short life span. H2S is involved in the multifunctional regulation of vasodilation, inflammation, cellular cycle, ischemia/reperfusion, oxidative stress and neuromodulation. Du et al2 firstly described H2S as a messenger molecule in cardiovascular system. Meanwhile, the role of H2S in inflammation has attracted growing interest in recent years as a large number of experiments have been performed to identify its effect in different animal models with multi-target approaches. Further studies have explored the molecular mechanism of action for H2S including the reaction with disulfide groups and metal ions in proteins to regulate enzymatic functions3 and the interplay between H2S and NO.4, 5 To date, DL-propargylglycine (PAG) and NaHS are the two principal chemical entities used in related investigations. PAG, an irreversible inhibitor of the H2S-synthesizing enzyme CSE, is permeable to biomembrane and inhibits CSE activity by blocking substrate cysteine from binding to the active site.6 NaHS produces H2S in vivo and serves as exogenous H2S donor. A number of studies have suggested that H2S may function as a promoter in inflammation. Hui et al7 firstly reported that endogenous H2S was involved in lipopolysaccharide (LPS)- and cecal ligation and puncture (CLP)-induced endotoxemia. Further studies showed that an increase in the expression of CSE and CBS and in the formation of H2S in tissue during LPS-induced endotoxemia, and PAG treatment ameliorated LPS-mediated injuries with a reduction of myeloperoxidase (MPO) activity.8 Likewise, PAG treatment decreased transcripts of pro-inflammatory chemokines IL-1β, IL-6, TNFα, monocyte chemotatic protein-1 (MCP-1), and macrophage inflammatory protein-2 (MIP-2) via translocation of NF-κB to its nuclear target gene in CLP-induced endotoxemia, which lead to an underproduction of these mediators in plasma and tissue.9 This decrease, in turn, accelerated the resolution of CLP-related inflammatory processes. In contrast, NaHS therapy exacerbated the responses. In the same inflammatory model, Zhang et al10,11 showed that the CSE/H2S system was upregulated and that administration of NaHS facilitated neutrophil recruitment and upregulated the level of adhesion molecules ICAM-1, P-selectin, and S-selectin. They also showed that, in healthy mice, NaHS was able to induce CXCR2 expression in neutrophils making it easier for CXC chemokines to bind to its receptor resulting in increased neutrophil migration directed by MIP-2. Similarly, PAG showed a protective effect against caerulein-induced pancreatitis and associated lung injury12 and against carrageenan-induced hindpaw odema.13 Of note, most of the experimental models were characterized by a response in the acute stage. Moreover, many of these experiments were related to bacteria- and edotoxin-induced inflammation. On the basis of these findings, an upregulated H2S system has a pro-inflammatory role, especially in the acute stage and in neutrophil-related inflammation. In contrast, increasing evidence has shown that H2S exerts an anti-inflammatory effect. Inflammation was attenuated by H2S in LPS-treated microglia via inhibition of the p38 MAPK14 and in ovalbumin-induced asthma with coordinated reduction of NOS2 activity.15 More recently, in a rat model of trinitrobenzene sulfonic acid induced-colitis,16 H2S donors had a protective role by reducing TNFα expression in tissue. More persuasively, inhibition of H2S formation in healthy rats induced inflammation and mucosal injury in the small intestine and colon by inhibiting the transcriptional expression of cyclooxygenase-2 and the synthesis of prostaglandin. Moreover, in a model of myocardial ischemia/reperfusion (I/R) injury, H2S treatment attenuated the inflammatory response by dampening the surge of inflammation-related cytokines IL-6, IL-8, and TNFα17 partly through inhibiting leukocyte infiltration18 and partly through reducing intercellular adhesion molecule 1 expression (ICAM-1) and neutrophil accumulation.19 Recently, H2S was reported to play a protective role in a model of apolipoprotein E knockout induced-atherosclerotic lesions by inhibiting ICAM-1 expression20 and in a model of oleic acid-induced acute lung injury via regulation of IL-6, IL-8 and IL-10.21 ICAM-1 induced leukocyte migration and attachment to the endothelium involved in inflammatory responses. In contrast with previous studies,11,13 Zanardo et al22 reported that activation of KATP channels was possibly one mechanism by which H2S suppressed aspirin-induced leukocyte adhesion and alleviated carrageenan-induced hindpaw odema and inflammatory lesions. In addition, we previously reported that H2S donor protected the myocardium against CVB3-driven injury on postinfection day 10,23 which was a model of lymphocyte-related inflammation. This finding suggested that H2S acted as an inhibitor in neurogenic, cardiopulmonary, and enterogenous inflammation. Of note, most of the experiments were relevant to the chronic inflammatory phase except for the I/R models. The pleiotropic effect of H2S in inflammation is displayed in Table 1.Table 1: The pleiotropic effect of H2S in inflammationBased on these findings, we can draw a firm conclusion that H2S is implicated in inflammation including the regulation of inflammatory cells, inflammatory cytokines and signal transduction; however, the data generated have often been complex and contradictory. These divergent effects raise the novel question of whether H2S is an antior pro-inflammatory mediator. In fact, the role of H2S in vascular tone was also bidirectional. H2S caused vasoconstriction at low concentrations by inhibiting NOS3 and vasorelaxation at high concentrations by opening KATP channels.24 The contradistinction of the effect of H2S in inflammation cannot be elucidated by the difference of experimental animal models alone. Given the dual role of H2S in vascular tension and in different inflammatory phases and given the interaction between H2S and NO, we postulate that H2S may exert a biphasic regulatory effect on inflammation. Increasing evidences support our viewpoint. H2S donor promoted the death of lymphocytes, which was indicated more in CD8+T lymphocytes and in NK cells with a rapid loss of mitochondrial membrane potential.25 Interestingly, H2S donor promoted the survival of granulocytes through inhibition of caspase-3 cleavage and p38 MAPK phosphorylation.26 Based on these observations, the pro-inflammatory effect in the H2S-treated animals occurs primarily in CLP- or LPS-induced acute inflammatory models,8–11 which may be the result of H2S preventing neutrophil apoptosis. In contrast, the anti-inflammatory effect occured principally in the late stage of inflammatory responses, such as in OVA-induced asthma,15 trinitrobenzene sulfonic acid induced-Colitis,16 and CVB3-induced myocarditis,23 which may be the result of H2S facilitating lymphocyte death. Additionally, an emerging study indicated that cisplatin-induced renal inflammation was related to the increases of neutrophil count and H2S content, inhibition of endogenous H2S with PAG showed protection.27 In mice with sepsis and acute lung injury, H2S treatment facilitated neutrophil infiltration and tissue edema.28 NaHS significantly aggravated burn-associated systemic inflammation in mice with an increase of MPO activities, a marker of neutrophil activation.29 Administration of H2S promoted neutrophil migration to inflammatory sites in mice with sepsis by activating KATP channel.30 These serial studies suggested that H2S can increase count and promote activation, infiltration and migration of neutrophil. It is well-known that inflammatory cells vary with different phases: the predominant effector cells are neutrophil in the early stage and lymphocyte in the later stage. The proor anti-inflammatory role depends on the cellular subsets involved. Another important explanation is the crosstalk between H2S and NO, including the interaction with NO when forming nitrosothiol to scavenge NO effect4 and the reaction with unsaturated bonds of fatty acids to modulate NO release.5 It is well-known that NO is an active gas messenger with multiple biological functions including modulation of inflammation. NO also possesses beneficial and detrimental properties due to its appropriate or excessive formation. At the same time, H2S plays a bilateral role in the modulation of vascular tension depending on its concentrations; therefore, it is reasonable to extrapolate the biphasic regulation of H2S in inflammation. Additionally, the counterbalance of this biphasic role may be a switch to regulate an intra- and extra-cellular inflammatory microenvironment depending on the spatial and temporal formation of H2S due to the tissue-specific expression of H2S-forming enzymes and the concentration, rapid oxidation, and short life cycle of H2S. Pro-factors can shift the balance to a pro-inflammatory response, while anti-factors can shift the balance to an anti-inflammatory response. Our viewpoint is based on a novel theory of a pathophysiological mechanism of H2S in inflammation, which would explain the divergences reported previously and contribute to understanding inflammatory diseases. In our previous study of CVB3-induced myocarditis,23 both PAG and NaHS treatments failed to demonstrate any pathologically myocardial changes on postinfection day 4, while H2S donor showed protection against necrosis and injuries in infected cardiac myocytes on day 10 after infection. This protection was possible because lymphocytes were implicated in an early anti-viral effect and in a late pro-inflammatory role. If the hypothesis is true, it will be meaningful to apply therapeutic strategies such as selective treatment. For example, downregulation of the H2S system will be beneficial to treat acute neutrophil-mediated inflammatory lesions while, conversely, upregulation of the H2S system will be protective in chronic inflammation injuries. It will be necessary to fully understand the advantages of using H2S as an appropriate therapeutic intervention. This new viewpoint should be tested in additional experimental models using additional approaches. Present data suggest different regulatory mechanisms by which H2S exerts different effects. Experiments are encouraged in physically, chemically and biologically caused-inflammatory animal models and in inflammation-related cells, such as polymorphonuclear leukocytes, RAW264.7 macrophages, NK cells, and lymphocytic subsets. More importantly, using PAG or NaHS, as indicated in recent studies, has limitations. PAG is not a CSE-specific inhibitor and experimental data would be influenced by other inhibited enzymes. PAG is also a lead-containing compound, the administration of which may produce toxic effects.31 To solve these problems, it is better to develop novel specific suppressants without toxicity or using a gene knockout, such as siRNA, or a transgenic technique. Likewise, NaHS is not an ideal H2S donor, which should be designed to be released gradually and be maintained in stable concentrations in vivo. In conclusion, the new concept of biphasic regulation of H2S in inflammation may contribute to understanding its "double-edged sword" effect and provide valuable therapies in the future.